Christine Kohn, MD, PharmD

Reference

1. Costa OS, Kohn CG, Kuderer NM, Lyman GH, Bunz TJ, Coleman CI
   Effectiveness and Safety of Rivaroxaban Compared to Low Molecular Weight Heparin in Patients with Cancer-Associated Venous Thromboembolism: A Real World Analysis.
   Published in Blood Advances, September 8, 2020; 4(17):4045-4051.
2. Caranfa JT, Kohn CG, Baker WL, Waitzman DM
   Monoclonal antibody therapy for neuromyelitis optica: a systematic review and meta-analysis.
   Published in Journal of Neurological Disorders, December 2019; 7(3):412.
3. Kohn CG, Alberts MJ, Peacock WF, Bunz TJ, Coleman CI
   Cost and inpatient burden of peripheral artery disease: Findings from the National Inpatient Sample.
   Published in Atherosclerosis, July 2019; 286:142-146. PMID: 31170647.
4. Dolinar R, Kohn CG, Lavernia F, Nguyen E
   The non-medical switching of prescription medications.
   Published in Postgraduate Medicine, June 2019; 131(5):335-341. PMID: 31081414.
5. Weeda ER, Caranfa JT, Lyman GH, Kuderer NM, Nguyen E, Coleman CI, Kohn CG*
   External validation of three risk stratification rules in patients presenting with pulmonary embolism and cancer.
   Published in Supportive Care in Cancer, March 2019; 27(3):921-925. PMID: 30090992.
6. Kohn CG, Singh P, Korytowsky B, Caranfa JT, Miller JD, Sill BE, Marshall AC, Parikh ND
   Humanistic and economic burden of hepatocellular carcinoma: systematic literature review.
   Published in American Journal of Managed Care, February 2019; 25(2 Spec No.). PMID: 30776212.
7. Kohn CG, Bunz TJ, Beyer-Westendorf J, Coleman CI
   Comparative risk of major bleeding with rivaroxaban and warfarin: Population-based cohort study of unprovoked venous thromboembolism.
   Published in European Journal of Haematology, February 2019; 102(2):143-149. PMID: 30328143.
8. Nguyen E, Coleman CI, Kohn CG, Weeda ER
   Ranolazine in patients with type 2 diabetes and chronic angina: A cost-effectiveness analysis and assessment of health-related quality-of-life.
   Published in International Journal of Cardiology, December 15, 2018; 273:34-38. PMID: 30266352.
9. Nguyen E, Weeda ER, Kohn CG, D'Souza BA, Russo AM, Noreika S, Coleman CI
   Wearable Cardioverter-defibrillators for the Prevention of Sudden Cardiac Death: A Meta-analysis.
   Published in Journal of Innovations in Cardiac Rhythm Management, 2018; 9(5):3151-3162. PMID: 32477809.
10. Kohn CG, Lyman GH, Beyer-Westendorf J, Spyropoulos AC, Bunz TJ, Baker WL, Eriksson D, Meinecke AK, Coleman CI
    Effectiveness and Safety of Rivaroxaban in Patients With Cancer-Associated Venous Thrombosis.
    Published in Journal of the National Comprehensive Cancer Network, May 2018; 16(5):491-497. PMID: 29752323.
11. Nguyen E, Caranfa JT, Lyman GH, Kuderer NM, Stirbis C, Wysocki M, Coleman CI, Weeda ER, Kohn CG*
    Clinical prediction rules for mortality in patients with pulmonary embolism and cancer to guide outpatient management: a meta-analysis.
    Published in Journal of Thrombosis and Haemostasis, February 2018; 16(2):279-292. PMID: 29215781.
12. Caranfa JT, Ali R, Francis I, Zichichi A, Bosco E, Coleman CI, Baker WL, Kohn CG*
    Mechanical endovascular therapy for acute ischemic stroke: An indirect treatment comparison between Solitaire and Penumbra thrombectomy devices.
    Published in PLoS One, March 7, 2018; 13(3). PMID: 29513676.
13. Weeda EW, Caranfa JT, Zeichner SB, Coleman CI, Nguyen E, Kohn CG*
    External Validation of Generic and Cancer-Specific Risk Stratification Tools in Patients with Pulmonary Embolism and Active Cancer.
    Published in Journal of the National Comprehensive Cancer Network, December 2017; 15(12):1476-1482. PMID: 29223985.
14. Weeda ER, Kohn CG, Peacock WF, Fermann GJ, Crivera C, Schein JR, Coleman CI
    External Validation of the Hestia Criteria for Identifying Acute Pulmonary Embolism Patients at Low Risk of Early Mortality.
    Published in Clinical and Applied Thrombosis/Hemostasis, October 2017; 23(7):769-774. PMID: 27225840.
15. Kohn CG, Zeichner SB, Chen Q, Montero AJ, Goldstein DA, Flowers CR
    Reply to Á. Benedict et al.
    Published in Journal of Clinical Oncology, September 10, 2017; 35(26):3086-3087. PMID: 28715248.
16. Kohn CG, Fermann GJ, Peacock WF, Wells PS, Baugh CW, Ashton V, Crivera C, Schein JR, Wildgoose P, Coleman CI
    Association between rivaroxaban use and length of hospital stay, treatment costs and early outcomes in patients with pulmonary embolism: a systematic review of real-world studies.
    Published in Current Medical Research and Opinion, September 2017; 33(9):1697-1703. PMID: 28665208.
17. Kohn CG, Weeda ER, Kumar N, Wells PS, Peacock WF, Fermann GJ, Wang L, Baser O, Schein JR, Crivera C, Coleman CI
    External validation of a claims-based and clinical approach for predicting post-pulmonary embolism outcomes among United States veterans.
    Published in Internal and Emergency Medicine, August 2017; 12(5):613-619. PMID: 28185131.
18. Kohn CG, Zeichner SB, Chen Q, Montero AJ, Goldstein DA, Flowers CF
    The Cost-Effectiveness of Immune Checkpoint Inhibition in BRAF Wild-Type Advanced Melanoma.
    Published in Journal of Clinical Oncology, April 10, 2017; 35(11):1194-1202. PMID: 28221865.
19. Nguyen E, Peacock WF, Fermann GJ, Ashton V, Concetta C, Wildgoose P, Schein JR, Coleman C, Kohn CG*
    External Validation of the Multivariable ‘In-Hospital Mortality for Pulmonary Embolism Using Claims Data’ Prediction Rule in the Premier Hospital Database.
    Published in European Heart Journal – Quality of Care and Clinical Outcomes, April 1, 2017; 3(2):157-159. PMID: 28927177.
20. Zeichner SB, Kohn CG, Goldstein DA
    Economics of ramucirumab for metastatic colorectal cancer.
    Published in Expert Review of Pharmacoeconomics & Outcomes Research, December 2016; 16(6):733-745. PMID: 27828732.
21. Diaby V, Adunlin G, Ali AA, Zeichner SB, de Lima Lopes G, Kohn CG, Montero AJ
    Cost-effectiveness analysis of 1st through 3rd line sequential targeted therapy in HER2-positive metastatic breast cancer in the United States.
    Published in Breast Cancer Research and Treatment, November 2016; 160(1):187-196. PMID: 27548074.
22. Weeda ER, Kohn CG, Peacock WF, Fermann GJ, Crivera C, Schein JR, Coleman CI
    Rivaroxaban versus Heparin Bridging to Warfarin Therapy: Impact on Hospital Length of Stay and Treatment Costs for Low-Risk Patients with Pulmonary Embolism.
    Published in Pharmacotherapy, October 2016; 36(10):1109-1115. PMID: 27548074.
23. Rozjabek HM, Coleman CI, Weeda ER, Peacock WF, Fermann GJ, Crivera C, Schein JR, Kohn CG*
    Effect of vital sign measurement timing on Pulmonary Embolism Severity Index (PESI) and simplified PESI 30-day mortality risk determination.
    Published in Thrombosis Research, May 2016; 141:8-10. PMID: 26946105.
24. Weeda ER, Kohn CG, Fermann GJ, Peacock WF, Tanner C, McGrath D, Crivera C, Schein JR, Coleman CI
    External validation of prognostic rules for early post-pulmonary embolism mortality: assessment of a claims-based and three clinical-based approaches.
    Published in Thrombosis Journal, March 14, 2016; 14:7. PMID: 26977136.
25. Diaby V, Ali AA, Adunlin G, Kohn CG, Montero AJ
    Parameterization of a disease progression simulation model for sequentially treated metastatic HER2-positive breast cancer patients.
    Published in Current Medical Research and Opinion, June 2016; 32(6):991-996. PMID: 26824145.
26. Kohn CG, Peacock FW, Fermann GJ, Bunz TJ, Crivera C, Shein JR, Coleman CI
    External validation of the In-hospital Mortality for PulmonAry embolism using Claims daTa (IMPACT) multivariable prediction rule.
    Published in International Journal of Clinical Practice, January 2016; 70(1):82-88. PMID: 26575855.
27. Coleman CI, Freemantle N, Kohn CG*
    Ranolazine for the treatment of chronic stable angina: a cost-effectiveness analysis from the UK perspective.
    Published in BMJ Open, November 6, 2015; 5(11). PMID: 26546142.
28. Coleman CI, Kohn CG, Crivera C, Schein JR, Peacock WF
    Validation of the multivariable In-hospital Mortality for PulmonAry embolism using Claims data (IMPACT) prediction rule within an all-payer inpatient administrative claims database.
    Published in BMJ Open, October 28, 2015; 5(10). PMID: 26510731.
29. Coleman CI, Kohn CG, Bunz TJ
    Derivation and validation of the In-hospital Mortality for PulmonAry embolism using Claims daTa (IMPACT) prediction rule.
    Published in Current Medical Research and Opinion, August 2015; 31(8):1461-1468. PMID: 26074196.
30. Mearns ES, Saulsberry WJ, White CM, Kohn CG, Lemieux S, Sihabout A, Salamucha I, Coleman CI
    Efficacy and safety of antihyperglycaemic drug regimens added to metformin and sulphonylurea therapy in Type 2 diabetes: a network meta-analysis.
    Published in Diabetic Medicine, December 2015; 32(12):1530-1540. PMID: 26104021.
31. Mearns ES, Coleman CI, Patel D, Saulsberry WJ, Corman A, Li D, Hernandez AV, Kohn CG*
    Index Clinical Manifestation of Venous Thromboembolism Predicts Early Recurrence Type and Frequency: A Meta-Analysis of Randomized Controlled Trials.
    Published in Journal of Thrombosis and Haemostasis, June 2015; 13(6):1043-1052. PMID: 25819920.
32. Mearns ES, Sobieraj DM, White CM, Saulsberry WJ, Kohn CG, Doleh Y, Zaccaro E, Coleman CI
    Comparative efficacy and safety of antidiabetic drug regimens added to metformin monotherapy in patients with type 2 diabetes: a network meta-analysis.
    Published in PLoS One, April 28, 2015; 10(4). PMID: 25919293.
33. Kohn CG, Mearns EM, Parker MW, Hernandez AV, Coleman CI
    Prognostic Accuracy of Clinical Prediction Rules for Early Post-Pulmonary Embolism All-Cause Mortality: A Bivariate Meta-Analysis.
    Published in Chest, April 1, 2015; 147(4):1043-1062. PMID: 25317677.
34. Kohn CG, Coleman CI, Michael White C, Sidovar MF, Sobieraj DM
    Mobility, Walking and Physical Activity in Persons with Multiple Sclerosis.
    Published in Current Medical Research and Opinion, September 2014; 30(9):1857-1862. PMID: 24803286.
35. Mearns ES, White CM, Kohn CG, Hawthorne J, Song JS, Meng J, Schein JR, Raut MK, Coleman CI
    Quality of vitamin K antagonist control and outcomes in atrial fibrillation patients: a meta-analysis and meta-regression.
    Published in Thrombosis Journal, June 24, 2014; 12:14. PMID: 25024644.
36. Mearns EM, Kohn CG, Song JS, Hawthorne J, Meng J, White CM, Raut MK, Schein JR, Coleman CI
    Meta-Analysis to Assess the Quality of Vitamin K Antagonist Control and Associated Outcomes in Venous Thromboembolism Patients.
    Published in Thrombosis Research, August 2014; 134(2):310-319. PMID: 24935672.
37. Kohn CG, Parker MW, Limone BL, Coleman CI
    Impact of Angina Frequency on Health Utility Values of Patients with Chronic Stable Angina.
    Published in Health and Quality of Life Outcomes, March 14, 2014; 12:39. PMID: 24628859.
38. Kohn CG, Parker MW, Limone BL, Coleman CI
    Cost-Effectiveness of Ranolazine Added to Standard-of-Care Treatment in Patients with Chronic Stable Angina Pectoris.
    Published in American Journal of Cardiology, April 15, 2014; 113(8):1306-1311. PMID: 24560062.
39. Kohn CG, Salaheen H, Borrup K, Rogers S, Lapidus G
    Correlates of drugs use and driving among undergraduate college students.
    Published in Traffic Injury Prevention, 2014; 15(2):119-124. PMID: 24345012.
40. Kohn CG, Sidovar MF, Kaur K, Zhu Y, Coleman CI
    Estimating a Minimal Clinically Important Difference for the EuroQol 5-Dimension Health Status Index in Persons with Multiple Sclerosis.
    Published in Health and Quality of Life Outcomes, May 5, 2014; 12:66. PMID: 24886430.
41. Kohn CG, Baker WL, Sidovar MF, Coleman CI
    Walking Speed and Health-Related Quality of Life in Multiple Sclerosis.
    Published in The Patient, 2014; 7(1):55-61. PMID: 24078332.
42. Kohn CG, Azeem M, Kluger J, Coleman CI
    Short-Term Consequences of Angiographically-Confirmed Coronary Stent Thrombosis.
    Published in PLoS One, 2013; 8(10). PMID: 24143219.
43. Coleman CI, Sidovar MF, Roberts MS, Kohn C
    Impact of Mobility Impairment on Indirect Costs and Health-Related Quality of Life in Multiple Sclerosis.
    Published in PLoS One, 2013; 8(1). PMID: 23355896.

‍